Myocardial Infarction Clinical Trial
Official title:
Effects of Oxygen Treatment on Mechanisms Involved in Ischemia-reperfusion Injury: A Single Center, Randomized, Controlled Pilot Study in Healthy Volunteers
Oxygen treatment is widely used in acutely ill patients. In particular, oxygen treatment is
routinely used in acute coronary syndrome (ACS) patients with suspected acute myocardial
infarction and variably recommended in ACS-guidelines, despite very limited data supporting a
beneficial effect.
Immediate re-opening of the acutely occluded infarct-related bloodvessel via primary
percutaneous coronary intervention (PCI) is the treatment of choice to limit ischemic injury
in the setting of ST-elevation ACS (STE-ACS). However, the sudden re-initiation of blood flow
achieved with primary PCI can give rise to further damage, so-called reperfusion injury.
Ischemia and reperfusion associated myocardial injury (IR-injury) involves a wide range of
pathological processes. Vascular leakage, activation of cell death programs, transcriptional
reprogramming, no reflow phenomenon and innate and adaptive immune activation all contribute
to tissue damage, thereby determining the infarct size. The effect of oxygen treatment on
these pathological processes, on the extent of IR-injury and the final infarct size in
STE-ACS patients has not previously been studied.
ACS is characterized by a systemic inflammation with typical elevations of soluble
inflammatory markers as well as changes in white blood cells. The inflammatory reaction might
be considered helpful in restoring myocardial tissue structure and function, but on the other
hand it might worsen IR-injury by activating various pathological processes. In human
experimental studies, Salmonella typhi vaccine has been used to create a standardized model
of systemic inflammation and when administered to healthy volunteers the vaccination has not
been associated with any adverse events.
In an ongoing register randomized multicentre clinical trial, the DETO2X (Determination of
role of oxygen in suspected acute myocardial infarction) study, the effect of oxygen on
morbidity and mortality in ACS patients is being investigated. In a substudy of the
DETO2X-trial, the investigators have planned to evaluate the effect of oxygen treatment on
IR-injury in STE-ACS as assessed by biomarkers reflecting various aspects of the pathological
processes involved.
The presented study is an experimental pilot study performed in healthy volunteers with a
Salmonella typhi vaccine-induced inflammation with the purpose of studying effects of oxygen
treatment on biological systems involved in the pathogenesis of IR- injury.
HYPOTHESIS The main hypothesis is that oxygen treatment can increase oxidative stress,
systemic inflammation, markers of apoptosis, matrix metalloproteinases (MMPs) and their
tissue inhibitor (TIMPs) in individuals subjected to endotoxin-induced inflammation. The
investigators also hypothesize that pretreatment with statins can prevent this oxygen effect.
AIMS
- To evaluate whether oxygen treatment can increase oxidative stress in healthy volunteers
subjected to vaccine-induced inflammation.
- To assess the effect of oxygen treatment on plasma levels of soluble markers of
apoptosis, MMPs and TIMPs in healthy volunteers with vaccine-induced inflammation.
- To study the effect of oxygen treatment on systemic inflammatory activity and leukocyte
subset distribution in healthy volunteers with vaccine-induced inflammation.
- To evaluate the effect of oxygen treatment on platelet aggregation in healthy volunteers
with vaccine-induced inflammation.
- To determine whether a potential oxygen effect on these cellular- and biomarkers can be
prevented by pretreatment with Atorvastatin.
- To serve as a pilot study and basis for power calculations for a future planned study:
"Effects of oxygen treatment on biomarkers of reperfusion damage and infarct size in
ST-elevation myocardial infarction patients undergoing primary PCI".
DESIGN The present study is an experimental randomized pilot study in healthy volunteers.
STUDY POPULATION The investigators intend to include 36 healthy male volunteers. Females will
not be included, due to the potential risk of hazardous effects of Salmonella typhi vaccine
and Atorvastatin to a fetus in case of pregnancy.
STUDY DESIGN
At the time of inclusion all study participants will be randomised into one of three
intervention groups:
Group 1) Salmonella typhi vaccine Group 2) Salmonella typhi vaccine + oxygen treatment Group
3) Salmonella typhi vaccine + oxygen treatment + Atorvastatin At 8.00 am on study day a
peripheral venous catheter will be inserted. This catheter will be used to collect blood
sample during the study day. In addition, peripheral oxygen saturation will be measured by
pulse oximetry. After baseline venous blood samples have been collected, all study
participants will receive 0.5 mL of the Salmonella typhi vaccine as an intramuscular
injection (Typhim Vi®, Sanofi Pasteur MSD, injection solution 25 microgram/0.5 mL).
Half an hour after vaccination is administered, oxygen treatment will be initiated (in group
2 and 3) at 6 L/min via Oxymask® and continued for 6 hours. During oxygen treatment
peripheral oxygen saturation will be measured by pulsoximetry. In group 3, a single dose of
Atorvastatin 80 mg will be given immediately prior to start of oxygen. Venous blood samples
will be collected at 3, 6 and 8 hours after baseline. After the 8-hour blood sampling, the
peripheral venous catheter will be removed and the study day ended.
An experienced registered nurse and a resident or specialist in Cardiology and Internal
Medicine will be present during the entire study day taking care of all study interventions,
collecting blood samples and register data into the case report form (CRF) including
potential adverse events.
EFFICACY OUTCOMES
- To determine the effect of oxygen treatment on biomarkers of oxidative stress,
apoptosis, matrix metalloproteinases, markers of inflammation and platelet aggregation
in healthy volunteers with Salmonella typhi vaccine-induced inflammation.
- To compare levels of these cellular- and biomarkers over time during an 8-hour study
day.
SUMMARY The presented study is an experimental randomized pilot study performed in healthy
volunteers with a Salmonella typhi vaccine-induced inflammation with the purpose of studying
to date unknown effects of oxygen treatment on biological systems involved in the
pathogenesis of IR- injury. As part of the DETO2X trial series, this study aims to contribute
essential knowledge to clarifying the role of oxygen in treatment of acute myocardial
infarction.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06013813 -
Conventional vs. Distal Radial Access Outcomes in STEMI Patients Treated by PCI
|
N/A | |
Completed |
NCT04507529 -
Peer-mentor Support for Older Vulnerable Myocardial Infarction Patients
|
N/A | |
Recruiting |
NCT06066970 -
Cardiac Biomarkers for the Quantification of Myocardial Damage After Cardiac Surgery
|
||
Recruiting |
NCT03620266 -
Effects of Bilberry and Oat Intake After Type 2 Diabetes and/or MI
|
N/A | |
Completed |
NCT04097912 -
Study to Gather Information to What Extent Patients Follow the Treatment Regimen of Low-dose Aspirin for Primary and Secondary Prevention of Diseases of the Heart and Blood Vessels
|
||
Completed |
NCT04153006 -
Comparison of Fingerstick Versus Venous Sample for Troponin I.
|
||
Completed |
NCT03668587 -
Feasibility and Security of a Rapid Rule-out and rule-in Troponin Protocol in the Management of NSTEMI in an Emergency Departement
|
||
Recruiting |
NCT01218776 -
International Survey of Acute Coronary Syndromes in Transitional Countries
|
||
Completed |
NCT03076801 -
Does Choral Singing Help imprOve Stress in Patients With Ischemic HeaRt Disease?
|
N/A | |
Recruiting |
NCT05371470 -
Voice Analysis Technology to Detect and Manage Depression and Anxiety in Cardiac Rehabilitation
|
N/A | |
Recruiting |
NCT04562272 -
Attenuation of Post-infarct LV Remodeling by Mechanical Unloading Using Impella-CP
|
N/A | |
Completed |
NCT04584645 -
A Digital Flu Intervention for People With Cardiovascular Conditions
|
N/A | |
Active, not recruiting |
NCT04475380 -
Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents
|
||
Not yet recruiting |
NCT06007950 -
Time-restricted Eating Study (TRES): Impacts on Anthropometric, Cardiometabolic and Cardiovascular Health
|
N/A | |
Withdrawn |
NCT05327855 -
Efficacy and Safety of OPL-0301 Compared to Placebo in Adults With Post-Myocardial Infarction (MI)
|
Phase 2 | |
Recruiting |
NCT02876952 -
High Intensity Aerobic Interval Training With Mediterranean Diet Recommendations in Post-Myocardial Infarct Patients
|
N/A | |
Completed |
NCT02711631 -
Feasibility and Effectiveness of Remote Virtual Reality-Based Cardiac Rehabilitation
|
N/A | |
Completed |
NCT02917213 -
Imaging Silent Brain Infarct And Thrombosis in Acute Myocardial Infarction
|
||
Completed |
NCT02305602 -
A Study of VentriGel in Post-MI Patients
|
Phase 1 | |
Completed |
NCT02382731 -
Interventions to Support Long-Term Adherence aNd Decrease Cardiovascular Events Post-Myocardial Infarction
|
N/A |